|
In the U.S. over 6.5 million individuals suffer from central nervous system (CNS) disorders such as Alzheimer’s, Parkinson’s, Huntington’s, Multiple Sclerosis, and Attention Deficit Hyperactivity Disorder (ADHD). To date, there are no known medical cures for these disorders, limited reliable treatment alternatives, and few dependable diagnosis techniques. "...designed to alleviate the large upfront research and development costs associated with starting an fMRI program" Because of the emerging acceptance of functional imaging indicators, fMRI is at the forefront of research relating to CNS disorders. With a significant body of scientific evidence indicating fMRI’s potential in translational research, many collaborative partnerships have formed to encourage the development of novel CNS treatment therapies.
In the future, fMRI may be used for numerous purposes including monitoring the recovery of stroke patients and evaluating treatment efficacy in individuals with CNS disorders. Physicians also hope to compare patient-specific brain function with a database of normative functionality, allowing comparisons between a CNS patient's brain patterns and the standard populous. Based on their findings, physicians may gain insights that improve treatment planning, surgical outcomes, and disease diagnosis.
How can Neurognostics Help?
The Neurognostics’ fMRI system was designed to alleviate the large upfront research and development costs associated with starting an fMRI program. Our expert staff can help develop customized fMRI solutions that address specific clinical research needs. From equipment acquisition and setup, to custom paradigm design and data processing solutions, we can partner with you throughout all phases of an fMRI-based research program.
Please contact Neurognostics for more information regarding our fMRI Research Solutions: 
Recent Functional MRI Research has been published in collaboration with Neurognostics:
|
